Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Efficacy Study of Pharmacokinetic(PK)/Pharmacodynamic(PD) Relationship of Monotherapy MORAb-004 in Metastatic Melanoma
ClinicalTrials.gov study NCT01335009. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Survey on PD Patients With Depressive Symptoms
ClinicalTrials.gov study NCT00614575. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous C
ClinicalTrials.gov study NCT04732494. IPD Sharing: YES. Countries: 6. Publications: 0.
A Safety and Preliminary Efficacy Study of SBT6290 Alone and in Combination With PD-(L)1 Inhibitors in Select Advanced Solid Tumors
ClinicalTrials.gov study NCT05234606. IPD Sharing: NO. Countries: 0. Publications: 1.
Translation and Validation of BELA-p-K for QoL Evaluation in PD Patients
ClinicalTrials.gov study NCT03073044. IPD Sharing: NO. Countries: 0. Publications: 3.
Anti-PD(L)1 and SBRT in the Treatment of Advanced, Platinum-Refractory Urothelial Carcinoma
ClinicalTrials.gov study NCT03287050. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC)
ClinicalTrials.gov study NCT03943550. IPD Sharing: YES. Countries: 5. Publications: 0.
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Stud
ClinicalTrials.gov study NCT05600309. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
ClinicalTrials.gov study NCT02409355. IPD Sharing: Not stated. Countries: 14. Publications: 0.
A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-954 in Healthy Adult Participants
ClinicalTrials.gov study NCT03870555. IPD Sharing: YES. Countries: 1. Publications: 0.
PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study
ClinicalTrials.gov study NCT04115410. IPD Sharing: Not stated. Countries: 0. Publications: 9.
Sitravatinib Plus Pembrolizumab in Patients With Advanced Treatment-Naïve PD-L1+ Non-Squamous NSCLC
ClinicalTrials.gov study NCT04925986. IPD Sharing: NO. Countries: 1. Publications: 0.
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03488251. IPD Sharing: NO. Countries: 1. Publications: 0.
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
ClinicalTrials.gov study NCT04696055. IPD Sharing: NO. Countries: 8. Publications: 0.
Functional Imaging of T-Cell Activation With [18F]F-AraG in Urothelial Carcinoma Patients Receiving Neoadjuvant Therapy or Patients With Cancer Receiving Standard of Care Anti-PD-1/L1
ClinicalTrials.gov study NCT03007719. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
ClinicalTrials.gov study NCT03457649. IPD Sharing: NO. Countries: 0. Publications: 1.
Effects and Mechanisms of RAS Training on Upper-limb Movements in PD Patients
ClinicalTrials.gov study NCT05782322. IPD Sharing: NO. Countries: 0. Publications: 14.
A Study to Evaluate the Safety, Tolerability, PK, and PD Effects of AZD2389 in Participants With Liver Fibrosis and Compensated Cirrhosis.
ClinicalTrials.gov study NCT06750276. IPD Sharing: YES. Countries: 3. Publications: 0.
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL
ClinicalTrials.gov study NCT02361346. IPD Sharing: NO. Countries: 10. Publications: 0.
The PK and PD of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM
ClinicalTrials.gov study NCT02582840. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.